ABANDONED - AFTER EX PARTE APPEAL
after ex parte appeal
on 18 Oct 2022
Last Applicant/ Owned by
5606 Albia Rd.
Bethesda
MD
20816
Serial Number
88246875 filed on 02th Jan 2019
Registration Number
N/A
Correspondent Address
KRISTEN S. RUISI
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
MANAMIX
Pharmaceutical preparations, namely, Synthetic tumor antigen peptide mixes for use in activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers Synthetic tumor antigen peptide mixes for use in the manufacture of pharmaceutical preparations for activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers
Classification Information
Class [001]
Chemical Products
Synthetic tumor antigen peptide mixes for use in the manufacture of pharmaceutical preparations for activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers
First Use Date in General
01st Jan 2019
First Use Date in Commerce
01st Jan 2019
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, Synthetic tumor antigen peptide mixes for use in activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers
First Use Date in General
01st Jan 2019
First Use Date in Commerce
01st Jan 2019
Mark Details
Serial Number
No 88246875
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 142698516514
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Oct 2022 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
| 18th Oct 2022 | ABANDONMENT - AFTER EX PARTE APPEAL |
| 18th Oct 2022 | EXPARTE APPEAL TERMINATED |
| 06th Sep 2022 | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF |
| 24th Jun 2022 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |
| 24th Jun 2022 | ACTION DENYING REQ FOR RECON E-MAILED |
| 24th Jun 2022 | SU - ACTION CONTINUING FINAL - WRITTEN |
| 16th Jun 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 16th Jun 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 16th Jun 2022 | ASSIGNED TO LIE |